Azusa Ujike-Asai

Title: Azusa Ujike-Asai: Innovator in Th2-Mediated Hyperimmune Response

Introduction

Azusa Ujike-Asai is a prominent inventor based in Obu, Japan. She has made significant contributions to the field of immunology, particularly in understanding Th2-mediated hyperimmune responses. With a total of 2 patents, her work has implications for allergy research and treatment.

Latest Patents

Her latest patent focuses on a nonhuman model animal of Th2-mediated hyperimmune response. The invention aims to provide a model that lacks PIR-B gene function, allowing for the analysis of the Th2-mediated immune response mechanism and the onset of allergies in vivo. This model is crucial for studying the hyper-response of B cells and developing inducers, promoters, or inhibitors for Th2-mediated immune responses. The model is prepared by integrating specific fragments of the mouse PIR-B gene into a targeting vector, which is then transferred into embryonic stem cells and injected into blastocysts.

Career Highlights

Azusa has worked with notable organizations, including the Japan Science and Technology Agency and the Japan Science and Technology Corporation. Her experience in these institutions has contributed to her expertise in immunological research and innovation.

Collaborations

One of her notable collaborators is Toshiyuki Takai, who has worked alongside her in various research endeavors.

Conclusion

Azusa Ujike-Asai's innovative work in developing a nonhuman model for studying Th2-mediated hyperimmune responses highlights her significant contributions to immunology. Her patents pave the way for advancements in allergy research and treatment strategies.